61 related articles for article (PubMed ID: 29289465)
21. Epigenetic silencing of AATK in acinar to ductal metaplasia in murine model of pancreatic cancer.
Ding LY; Hou YC; Kuo IY; Hsu TY; Tsai TC; Chang HW; Hsu WY; Tsao CC; Tian CC; Wang PS; Wang HC; Lee CT; Wang YC; Lin SH; Hughes MW; Chuang WJ; Lu PJ; Shan YS; Huang PH
Clin Epigenetics; 2020 Jun; 12(1):87. PubMed ID: 32552862
[TBL] [Abstract][Full Text] [Related]
22. Epigenomics of Pancreatic Cancer: A Critical Role for Epigenome-Wide Studies.
Singh RR; Reindl KM; Jansen RJ
Epigenomes; 2019 Mar; 3(1):. PubMed ID: 31772762
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive analysis of differentially expressed circRNAs revealed a ceRNA network in pancreatic ductaladenocarcinoma.
Zhou JZ; Hu MR; Diao HL; Wang QW; Huang Q; Ge BJ
Arch Med Sci; 2019 Jul; 15(4):979-991. PubMed ID: 31360192
[TBL] [Abstract][Full Text] [Related]
24. The role of lineage specifiers in pancreatic ductal adenocarcinoma.
Camolotto SA; Belova VK; Snyder EL
J Gastrointest Oncol; 2018 Dec; 9(6):1005-1013. PubMed ID: 30603119
[TBL] [Abstract][Full Text] [Related]
25. Transcription factor Ptf1a in development, diseases and reprogramming.
Jin K; Xiang M
Cell Mol Life Sci; 2019 Mar; 76(5):921-940. PubMed ID: 30470852
[TBL] [Abstract][Full Text] [Related]
26. Investigation of HNF-1B as a diagnostic biomarker for pancreatic ductal adenocarcinoma.
Yang MX; Coates RF; Ambaye A; Gardner JA; Zubarick R; Gao Y; Skelly J; Liu JG; Mino-Kenudson M
Biomark Res; 2018; 6():25. PubMed ID: 30065837
[TBL] [Abstract][Full Text] [Related]
27. Molecular pathology of pancreatic cancer.
Saiki Y; Horii A
Pathol Int; 2014 Jan; 64(1):10-9. PubMed ID: 24471965
[TBL] [Abstract][Full Text] [Related]
28. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H
J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261
[TBL] [Abstract][Full Text] [Related]
29. Pdx1 expression in pancreatic precursor lesions and neoplasms.
Park JY; Hong SM; Klimstra DS; Goggins MG; Maitra A; Hruban RH
Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):444-9. PubMed ID: 21297446
[TBL] [Abstract][Full Text] [Related]
30. Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of Intraductal Papillary Mucinous Neoplasms in Mice.
Yamaguchi J; Mino-Kenudson M; Liss AS; Chowdhury S; Wang TC; Fernández-Del Castillo C; Lillemoe KD; Warshaw AL; Thayer SP
Gastroenterology; 2016 Dec; 151(6):1232-1244.e10. PubMed ID: 27523981
[TBL] [Abstract][Full Text] [Related]
31. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.
Aichler M; Seiler C; Tost M; Siveke J; Mazur PK; Da Silva-Buttkus P; Bartsch DK; Langer P; Chiblak S; Dürr A; Höfler H; Klöppel G; Müller-Decker K; Brielmeier M; Esposito I
J Pathol; 2012 Apr; 226(5):723-34. PubMed ID: 21984419
[TBL] [Abstract][Full Text] [Related]
32. Investigating the role of transcription factors of pancreas development in pancreatic cancer.
Naqvi AAT; Hasan GM; Hassan MI
Pancreatology; 2018 Mar; 18(2):184-190. PubMed ID: 29289465
[TBL] [Abstract][Full Text] [Related]
33. Molecular mechanism of intraductal papillary mucinous neoplasm and intraductal papillary mucinous neoplasm-derived pancreatic ductal adenocarcinoma.
Fukuda A
J Hepatobiliary Pancreat Sci; 2015 Jul; 22(7):519-23. PubMed ID: 25900667
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
